Skip to main content

Dextran or Gelatin?

  • Chapter
  • 31 Accesses

Abstract

In 1957 Grönwall [575] listed the requirements which an artificial colloid infusion solution should fulfill (see p. 49 f.). We confirmed that dextran 70 corresponds to these requirements for the most part, while gelatin does not fulfill point 4 with regard to intravascular persistence. Nor does gelatin in any way fulfill the point dealing with the same problem in the requirements set up in 1963 by the American National Research Council [1074]: “It should be retained to the extent of 50% of the infused volume for at least 6, and preferably for 12 hours”.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1969 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gruber, U.F. (1969). Dextran or Gelatin?. In: Blood Replacement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-49790-2_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-49790-2_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-49504-5

  • Online ISBN: 978-3-642-49790-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics